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Idiopathic pulmonary fibrosis (IPF) causes progressive fibrosis and worsening pulmonary
function. Prognosis is poor and no effective therapies exist. We show that programmed cell
death 5 (PDCD5) expression is increased in the lungs of patients with IPF and in mouse
models of lung fibrosis. Lung fibrosis is significantly diminished by club cell-specific deletion
of Pdcd5 gene. PDCD5 mediates β-catenin/Smad3 complex formation, promoting TGF-β-
induced transcriptional activation of matricellular genes. Club cell Pdcd5 knockdown reduces
matricellular protein secretion, inhibiting fibroblast proliferation and collagen synthesis. Here,
we demonstrate the club cell-specific role of PDCD5 as a mediator of lung fibrosis and
potential therapeutic target for IPF.
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Idiopathic pulmonary fibrosis (IPF) is a lethal and progressivelung disease that affects millions of patients worldwide andcauses scarring of the lungs. The cause of IPF is unknown and
it is largely unaffected by current treatments1. Additionally, the
key cellular and molecular events in early-stage IPF are poorly
understood. The lungs of IPF patients display a characteristic
fibrosis, which also been termed usual interstitial pneumonia. A
typical interstitial pneumonia usually includes the presence of
fibroblast foci, characterized by deposition of extracellular matrix
(ECM), which results in distortion of normal lung structures and
loss of respiratory function2. Since there is no effective therapy for
IPF which has a mortality rate higher than many cancers, effective
therapeutic targets, and treatments are urgently needed.
Club cells are non-ciliated bronchiolar epithelial cells with
diverse functions including xenobiotic metabolism, immune
system regulation through secretion of club cell secretory protein
(CCSP), and progenitor cell activity to repair the regional epi-
thelium in response to lung damage3. The role of club cells in IPF
or other lung diseases is still unclear; however, there is a link
between lung fibrosis and alveolar bronchiolization, a process by
which club cells and other bronchiolar epithelial cell types
migrate to fill the alveolar walls4,5. Interestingly, a recent study
reported perspective on the potential pathological role of club
cells in IPF, suggesting that club cells induce pulmonary epithelial
cell death, leading to IPF progression6. In addition, club cell-
specific overexpression of transforming growth factor alpha
(TGF-α) activates mesenchymal cell migration and accumulation
in lung fibrosis7. Despite the growing focus on club cells in recent
years, the accumulated interest of club cells in the IPF field is very
low compared with that of alveolar type II (AT2) cells. Therefore,
additional studies are needed to clarify the role of club cells in the
pathogenesis of pulmonary fibrosis.
Human programmed cell death 5 (PDCD5) is an apoptosis-
associated gene located on chromosome 19q12–q13.1; the
PDCD5 protein contains 125 amino acid residues. The expression
of PDCD5 in various cell lines demonstrates that it has diverse
functions in pathological and physiological processes8. PDCD5
inhibits the function of HDAC3 and promotes activation of p53
to induce apoptosis9. In addition, PDCD5 reduces nitric oxide
production by inhibiting the physical interaction between AKT
and HDAC3 in endothelial cells without affecting apoptosis10.
Thus, PDCD5 participates in varied cellular signaling pathways
via regulation of protein–protein interactions. Reduced expres-
sion of PDCD5 is common in human tumors, including gastric,
breast, astrocytic glioma, chronic myelogenous leukemia, and
hepatocellular carcinoma8. PDCD5 is also implicated in inflam-
matory conditions like osteoarthritis and rheumatoid arthritis,
paraptosis, cell cycle regulation, ischemia/reperfusion, and
immunoregulation and viral infection11. However, the role of
PDCD5 in pulmonary fibrosis has not been explored.
In this study, we found elevated expression of PDCD5 in the
lungs of patients with IPF and mouse models of lung fibrosis.
Using mice with club cell-specific Pdcd5 conditional knockout
(Ccsp-Pdcd5d/d) and AT2 cell-specific Pdcd5 conditional knock-
out (Spc-Pdcd5d/d), we show that PDCD5 plays a selective role in
club cells during pulmonary fibrosis initiation. Furthermore,
PDCD5 is required for formation of TGF-β-induced Smad3/β-
catenin complexes on the promoter region of secreted matricel-
lular genes in club cells. p38 MAPK phosphorylates Ser-119 of
PDCD5, which enhances stability and nuclear localization of
PDCD5. Finally, we verify that selective activity of PDCD5 in club
cells promotes fibroblast proliferation and collagen synthesis via a
paracrine loop. Our findings highlight the functional significance
of PDCD5 in pulmonary fibrosis and suggest a conceptual fra-
mework for understanding the interconnectivity between club
cells and pulmonary fibrosis.
Results
Expression of PDCD5 is elevated in the lungs of patients with
IPF and in mouse models of lung fibrosis. To investigate the
pathological relevance of PDCD5 in lung disease, we examined
PDCD5 expression in lung tissues from patients with IPF using
immunohistochemistry (IHC). Demographic and clinical char-
acteristics of lung tissue from control subjects and IPF patients are
summarized in Supplementary Table 1. The IPF group was male
dominant; age and body weights were balanced between the two
groups. Lung function parameters, including forced vital capacity
(FVC), forced expiratory volume in 1 s (FEV1), and diffusing
capacity for carbon monoxide (DLCO), were significantly lower in
patients with IPF compared with control (p < 0.001). As shown in
Fig. 1a, b, PDCD5 was significantly increased in samples from IPF
patients compared to those from control subjects. To further
validate the expression of PDCD5 in honeycomb cysts and rela-
tively normal airway tissue from IPF lung samples, immuno-
fluorescence (IF) analysis was performed. Elevated levels of
PDCD5 was observed in honeycomb cysts compared with normal
airway tissue in IPF lungs (Supplementary Fig. 1a–c).
Bleomycin (BLM) is widely used for acute induction of lung
fibrosis in mice and increases TGF-β1 level which is potent
fibrogenic cytokine that plays a critical role in IPF pathogenesis12.
Masson’s trichrome staining (MTS) showed that BLM induced
fibrotic changes by day 14 in interstitial areas of the mouse lung.
Importantly, PDCD5 levels were significantly increased in the lungs
of mice following BLM injection (Fig. 1c and Supplementary
Fig. 1d). TGF-β is a major inducer of epithelial–mesenchymal
transition (EMT) and a key mediator of fibrosis in many tissues
including the lung and kidney13. To further verify induction of
PDCD5 expression in TGF-β-driven lung fibrosis, we next
evaluated changes in PDCD5 expression in a transgenic mouse
model with inducible overexpression of TGF-β1 (Ccsp-TGFβ1-TG
mice), which induces lung fibrosis after administration of
doxycycline (Dox). After 28 days of Dox adiministration, PDCD5
was significantly increased in the lungs of Ccsp-TGFβ1-TG mice
compared to lungs from wild-type mice (Fig. 1d and Supplementary
Fig. 1e). Bronchial lavage (BAL) fluid cell counting revealed that
inflammatory cells were induced in the severe lung fibrosis mouse
models (Supplementary Fig. 2a, b). Using co-IF analysis, we found
that expression of PDCD5 was significantly increased in patients
with IPF in club cells and AT2 cells, but not in AT1 cells (Fig. 1e left
panel, f). We observed similar expression patterns in both Ccsp-
TGFβ1-TG mice (Fig. 1e right panel, g) and BLM-induced fibrosis
model mice (Supplementary Fig. 2c).
To further evaluate the co-expression of PDCD5 with other
epithelial cell makers in IPF patients, co-IF staining was
performed using Muc5AC (a goblet cell marker), Foxj1 (a ciliated
cell marker) antibodies, and a Scgb3a2 antibody, which is another
club cell marker. Similar to the results obtained from the IF
analysis using CCSP, which showed the co-localization of PDCD5
with another club cell marker, the co-expression between PDCD5
and Scgb3a2 was significantly increased in IPF patients, but
PDCD5 co-localization did not increase significantly with goblet
cell or ciliated cell markers. Intriguingly, we also observed that
PDCD5 was highly co-localized with a fibroblast marker, α-
smooth muscle actin (α-SMA) in IPF patients, suggesting a
plausible role for PDCD5 in myofibroblast activation during IPF
development (Supplementary Fig. 2d). These results collectively
demonstrate that PDCD5 expression increases in IPF and mouse
models of lung fibrosis.
Lung fibrosis is regulated by PDCD5 in a lung club cell-specific
manner. To determine the physiological role of PDCD5 in the
development of lung fibrosis, we generated a genetically
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engineered mouse model with tamoxifen-inducible Pdcd5 abla-
tion in lung epithelial club cells14–16 (Ccsp-Pdcd5d/d) or AT2
cells17 (Spc-Pdcd5d/d). First, to verify Cre activity in club cells and
AT2 cells after 4-OHT treatment which is a metabolite of the
tamoxifen, we adapted a dual fluorescent membrane-localized
tdTomato/eGFP (mTmG) indicator mouse model, which marks
Cre-mediated excision via a heritable switch from tdTomato
expression to eGFP expression18. We crossed this Rosa26-mTmG
mouse with either Ccsp-Pdcd5d/d or Spc-Pdcd5d/d mice to visualize
the Cre-mediated excision of Pdcd5 in club cells or AT2 cells,
respectively. The bronchiolar epithelia of the resulting Ccsp-
Pdcd5d/d;mTmG mice displayed bright eGFP expression, whereas
the bronchiolar epithelia of Pdcd5f/f;mTmG mice lacked eGFP
expression (Supplementary Fig. 3a). Additionally, eGFP+ cells
b 
e 






IPF patient 1 































Control  IPF   
Human  (Ccsp-TGF 1-TG)  
Mouse 


















































































































































NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-021-23277-8 ARTICLE
NATURE COMMUNICATIONS |         (2021) 12:2923 | https://doi.org/10.1038/s41467-021-23277-8 | www.nature.com/naturecommunications 3
were expressed in the alveolar area of Spc-Pdcd5d/d;mTmG mouse
lungs, whereas Pdcd5f/f;mTmG mice lacked eGFP signal in the
alveolar region (Supplementary Fig. 3b). Increased eGFP intensity
was observed in the airways of Ccsp-Pdcd5d/d;mTmGmice after 4-
OHT treatment. In contrast, 4-OHT-induced eGFP signal was
observed in the parenchymal region of Spc-Pdcd5d/d;mTmG mice.
To verify Pdcd5 ablation in the respective lung epithelial cells
from Ccsp-Pdcd5d/d and Spc-Pdcd5d/d mouse lungs, PDCD5
expression was verified by co-IF analysis with cell type-specific
markers (Supplementary Fig. 4a, b). Furthermore, the deletion of
Pdcd5 was confirmed by quantitative reverse transcription-PCR
(qRT-PCR) in isolated primary club cells and AT2 cells, which
were obtained from each knockout mouse using fluorescence-
activated cell sorting (FACS, Supplementary Fig. 4c–f).
Next, we induced lung fibrosis in these mouse models using
BLM injection through the trachea. We found that BLM-induced
lung fibrosis was markedly diminished in Ccsp-Pdcd5d/d mice,
quantified using MTS-stained areas in the lung and soluble
collagen content via Sircol Collagen Assay (Fig. 2a, b). In contrast,
there were no significant changes related to fibrosis and collagen
synthesis in Spc-Pdcd5d/d mice (Fig. 2c and Supplementary
Fig. 5a). To further examine the role of PDCD5 in club cell-
specific lung fibrosis, inducible Ccsp-TGFβ1-TG mice were bred to
Ccsp-Pdcd5d/d mice to generate ablation of Pdcd5 and over-
expression of TGF-β1 in the club cells (Supplementary Fig. 5b).
Following administration of Dox, wild-type mice developed lung
fibrosis; however, previously observed increased lung fibrosis was
significantly diminished in Ccsp-Pdcd5d/d mice (Fig. 2d and
Supplementary Fig. 5c). Moreover, we compared the survival rate
after BLM injection in both club cell- and AT2 cell-specific Pdcd5
knockout mice. Kaplan–Meier survival analysis demonstrated
there was prolonged survival in Ccsp-Pdcd5d/d mice (Fig. 2e),
whereas there was no significant survival change in Spc-Pdcd5d/d
mice (Fig. 2f). Importantly, club cell-specific knock-out of Pdcd5
gene had no effects on induction of PDCD5 expression by BLM
in both AT2 cells and fibroblasts (Supplementary Fig. 6). These
data suggested that PDCD5 in the club cells plays an important
role in the initiation of lung fibrosis.
To further validate the functional role played by PDCD5 in the
initiation of pulmonary fibrosis, we performed the genetic
deletion of Pdcd5 after the induction of lung fibrosis. We first
examined the time course of lung fibrosis induction following
BLM injection. We found that BLM significantly induced lung
fibrosis and PDCD5 expression starting 3 days after injection
(Supplementary Fig. 7a). Thus, Ccsp-Pdcd5d/d mice were treated
with 4-OHT, 3 days after BLM injection. As shown in
Supplementary Fig. 7b, the induction of lung fibrosis following
BLM injection was significantly suppressed by deletion of Pdcd5
gene from 2 days after first 4-OHT injection. These data revealed
PDCD5 mediates lung fibrosis initiation. It was also noteworthy
that Pdcd5 depletion did not affect cell death of lung
(Supplementary Fig. 8a). Furthermore, we examined the effects
of Pdcd5 deletion on the proliferation of club cells through IF
analysis, using antibodies against Ki67 and CCSP (Supplementary
Fig. 8b). Pdcd5 ablation did not appear to affect the proliferation
of club cells. Taken together, our results suggest that PDCD5
mediates lung fibrosis initiation, without affecting club cell death
and proliferation.
PDCD5 promotes TGF-β signaling by mediating formation of
a Smad3/PDCD5/β-catenin complex. We next examined the
molecular mechanism by which PDCD5 mediates lung fibrosis in
club cells. To do this, we used conditionally immortalized C22
mouse club cells. We previously showed that in response to
genotoxic stress, levels of PDCD5 and phosphorylated PDCD5
concurrently increase in HCT-116 cells9,19. We thus examined
whether TGF-β1 treatment changes PDCD5 expression and/or
phosphorylation in C22 cells. After 1 h of TGF-β1 treatment, both
total and phosphorylated levels of PDCD5 were increased, and
PDCD5 expression was continuously stimulated until 12 h post-
treatment. As expected, both Smad2 and Smad3 phosphorylation
were also induced early following TGF-β treatment in C22 cells
(Fig. 3a). However, no significant change in PDCD5 phosphor-
ylation and expression was observed following TGF-β1 treatment
in the RLE-6TN AT2 cell line (Supplementary Fig. 9a).
To determine whether PDCD5 is involved in transcriptional
regulation of TGF-β target genes, we performed RNA sequencing
(RNA-seq) analysis in C22 club cells with or without knocking-
down of Pdcd5 after 24 h of TGF-β1 treatment. Gene set
enrichment analysis (GSEA) demonstrated significant enrichment
of ECM genes in TGF-β1-treated C22 cells. However, Pdcd5
knockdown negatively regulated ECM Gene Ontology (GO)-
defined genes (Fig. 3b). Among TGF-β-regulated ECM genes, the
top 10 included matricellular genes such as periostin (Postn),
plasminogen activator inhibitor-1 (Serpine1), connective tissue
growth factor (Ctgf), thrombospondin 2 (Thbs2), and tenascin C
(Tnc); these genes were significantly down-regulated following
Pdcd5 knockdown in TGF-β1-treated C22 cells. Additionally, we
verified our RNA-seq data with quantitative RT-PCR (Supple-
mentary Fig. 9b). In contrast to our findings in C22 cells, Pdcd5
knockdown had no effects on the mRNA levels of these
matricellular genes in AT2 cells (Supplementary Fig. 9c). These
findings were again verified using primary club cells and AT2
cells from Ccsp-Pdcd5d/d and Spc-Pdcd5d/d mouse lungs (Fig. 3c).
Collectively, these findings suggest that PDCD5 selectively
regulates transcription of pro-fibrotic matricellular genes in the
club cells.
β-Catenin interacts with Smad3 on TGF-β target gene
promoters in lung epithelial cell lines, leading to EMT and
fibrosis20. Since PDCD5 acts as a molecular chaperone by
mediating protein–protein interaction8, we next examined
whether PDCD5 interacts with β-catenin or Smad3. Co-
immunoprecipitation analysis showed that endogenous PDCD5
interacts with β-catenin and Smad3 in the nucleus; these
interactions were further enhanced following treatment with
TGF-β1 in C22 cells (Supplementary Fig. 10a). We also verified
Fig. 1 Elevated expression of PDCD5 in IPF patients and in a mouse lung fibrosis model. a IHC with an anti-PDCD5 antibody performed in two
representative samples from control subjects and IPF patients, respectively. Scale bars= 100 μm. b Dot plot represents PDCD5 intensity/H&E ratio from
IPF patients (n= 19) and the control subjects (n= 10). IPF vs. control; 1.7 (1.6–2.4) vs. 0.6 (0.4–0.9), p < 0.001, two-tailed Mann–Whitney test. Error bars,
mean ± s.e.m. c, d Representative images showing PDCD5 IHC and MTS in BLM-induced fibrosis lung of wild type (c) and TGF-β transgenic mouse (d)
(scale bars= 100 μm). PDCD5 and H&E intensities and MTS areas were analyzed using ImageJ software. Error bars, mean ± s.e.m. (n= 5 mice/group); **p
< 0.008, two-tailed Mann–Whitney test (c, d). e Immunofluorescence assay was carried out with human and mouse lung tissue using indicated antibodies.
Scale bars= 50 μm. CCSP is a club cell marker; Pro-SPC is an AT2 cell marker; and PDPN is an AT1 cell marker. Co-localized PDCD5 and each marker is
indicated by white arrowheads (scale bars= 50 μm). f, g Weighted co-localized coefficient was calculated using ZEN 3.0 software. Error bars, mean ± s.e.
m. n= 3 in each group except CCSP-IPF and SPC-IPF groups (n= 6). *p < 0.0357; n.s. not significant, two-tailed Mann–Whitney test (f). **p < 0.009; n.s.
not significant, unpaired two-tailed t-test (g). Source data are provided in the Source Data file.
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the selective interaction of PDCD5 with Smad3 but not with other
Smad proteins (Supplementary Fig. 10b). An in vitro binding
assay showed that PDCD5 directly interacts with β-catenin, but
not Smad3 (Supplementary Fig. 10c). We next tested whether
PDCD5 is required for formation of the Smad3/β-catenin
complex in a response to TGF-β stimuli. Following Pdcd5
knockdown, TGF-β-induced Smad3/β-catenin interaction was
abolished in the nucleus in C22 cells (Fig. 3d). An in situ
proximal ligation assay also verified that the TGF-β-induced
Smad3/β-catenin interaction occurred in the nucleus and that this
signal was reduced following the Pdcd5 knockdown in C22 club
cells (Supplementary Fig. 10d). Furthermore, the level of BLM-
induced Smad3/β-catenin interaction was significantly dimin-
ished by Pdcd5 deletion in primary club cells but not in AT2
cells (Fig. 3e and Supplementary Fig. 10e). As reported previously,
both Smad3 and β-catenin were translocated into the nucleus
upon TGF-β1 treatment20; however, Pdcd5 knockdown signifi-
cantly reduced TGF-β-induced nuclear translocation of both
Smad3 and β-catenin (Fig. 3f and Supplementary Fig. 10f).
Because the Smad3/β-catenin complex binds to the promoter
region of TGF-β target genes, such as Ctgf, we tested whether
PDCD5 is also recruited to same Smad-binding element in the
Ctgf gene. Chromatin immunoprecipitation (ChIP) analysis
showed that the PDCD5/β-catenin/Smad3 complex is recruited
to the Smad-binding element of Ctgf gene in a response to TGF-
β1 treatment in C22 cell line. Importantly, this recruitment was
abolished following Pdcd5 knockdown (Fig. 3g). We observed
similar effect on another matricellular gene, Postn (Supplemen-
tary Fig. 10g). These results indicate that PDCD5 promotes
TGF-β-induced transcriptional activation of matricellular
genes by mediating formation of the PDCD5/β-catenin/Smad3
complex.
Fig. 2 Club cell-specific deletion of Pdcd5 prevents lung fibrosis. a MTS was carried out on lung tissues from Pdcd5f/f and Ccsp-Pdcd5d/d mice with or
without BLM treatment (scale bars= 200 μm). b–d MTS quantification and soluble collagen assay using lung tissues from Pdcd5f/f and Ccsp-Pdcd5d/d mice
(b), Pdcd5f/f and Spc-Pdcd5d/d mice (c), and Ccsp-TGFβ1-TG (d), respectively (n= 5 mice/group). Error bars represents mean ± s.e.m. Statistical analysis
was performed with ANOVA with Tukey’s test. ***p < 0.001; *p= 0.029 (b–d). e Kaplan–Meier survival analysis was performed after BLM injection.
Pdcd5f/f (n= 7 mice) and Ccsp-Pdcd5d/d (n= 8 mice), p= 0.0025. f Kaplan–Meier survival of Pdcd5f/f and Spc-Pdcd5d/d (n= 5 mice/group), p= 0.6731.
Statistical analysis was performed using log-rank (Mantel–Cox) test (e, f). Source data are provided in the Source Data file.
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p38 MAPK phosphorylates PDCD5 Ser-119, leading to
PDCD5 stabilization and nuclear translocation in a response
to TGF-β. Casein kinase 2 (CK2) phosphorylates PDCD5 at Ser-
119 upon genotoxic stress, which enhances its stability and pro-
motes translocation into the nucleus9,21. Since PDCD5 expression
was increased in the lungs of patients with IPF and in the lungs of
mice with fibrosis, we examined whether CK2-mediated
phosphorylation of PDCD5 at Ser-119 is required for
PDCD5 stabilization and nuclear translocation in response to
TGF-β1. First, we tested whether PDCD5 phosphorylation at Ser-
119 is required for TGF-β-induced nuclear translocation of
PDCD5. Wild-type PDCD5 (PDCD5WT) was rapidly translo-
cated into the nucleus upon TGF-β1 treatment. However, a
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the nucleus, even with TGF-β1 treatment. Importantly, a
phospho-mimetic form of PDCD5 (PDCD5S119E) was localized
primarily in the nucleus even without TGF-β1 treatment (Fig. 4a
and Supplementary Fig. 11a). Together, these results suggest that
phosphorylation of Ser-119 is required for nuclear translocation
of PDCD5 in response to TGF-β.
Next, we examined whether CK2 phosphorylates PDCD5 in
response to TGF-β. Unexpectedly, neither TBB, a specific
inhibitor against CK2, nor knock down had an effect on PDCD5
expression in response to TGF-β (Fig. 4b and Supplementary
Fig. 11b), indicating that another kinase is responsible for TGF-β-
induced phosphorylation of PDCD5 at Ser-119. To identify the
kinase responsible for PDCD5 phosphorylation at Ser-119, C22
cells were treated with kinase-specific inhibitors involved in
signaling upstream of TGF-β. Among those inhibitors, the p38
inhibitor SB203580, significantly inhibited TGF-β-induced
PDCD5 phosphorylation at Ser-119 (Fig. 4b, c and Supplemen-
tary Fig. 11c). TGF-β-induced Postn and Ctgf mRNA expression,
as well as PDCD5 nuclear translocation were also blocked
following treatment with SB203580 (Fig. 4d, e and Supplementary
Fig. 11d). To examine whether p38 MAPK promotes the
phosphorylation and stabilization of PDCD5, we assessed PDCD5
protein levels following the overexpression or knockdown of p38
MAPK in C22 cells. The stabilization of PDCD5 was regulated in
a p38 MAPK expression-dependent manner (Supplementary
Fig. 11e). Neither total nor phosphorylated levels of PDCD5 were
increased upon TGF-β treatment in the RLE-6TN cell line.
Moreover, p38 MAPK activation occurred after TGF-β treatment
in C22 cells but not in the RLE-6TN line (Fig. 3a and
Supplementary Fig. 9a). An in vitro kinase assay revealed that
p38 directly phosphorylates PDCD5, and this phosphorylation
was completely blocked by SB203580 treatment (Fig. 4f). These
results suggest that p38 kinase directly phosphorylates PDCD5 at
Ser-119 to promote its stability and nuclear translocation in
response to TGF-β1 treatment.
PDCD5-mediated matricellular proteins secretion in club cell
promotes fibroblast activation. During pulmonary fibrosis, the
abnormal airway epithelium secretes numerous paracrine factors
that lead to deposition of pathological matrix by activated
fibroblasts22. Therefore, we next examined the functional role of
PDCD5 in epithelial club cells following fibroblast activation.
Using epithelial-fibroblast co-culture analysis, we found that
proliferation of primary mouse lung fibroblasts (MLFs) was sig-
nificantly decreased following Pdcd5 knockdown in epithelial C22
cells (Fig. 5a). Following Pdcd5 knockdown in C22 cells and co-
culture with MLFs, we found that fibrotic target genes including
Collagen1a1 (Col1a1), Col1a2, Col1a3, alpha-Smooth Muscle
Actin (α-SMA), Fibronectin (FN), and Snail were also reduced in
MLF cells (Fig. 5b). We obtained similar results using Mlg
fibroblasts co-cultured with C22 club cells (Supplementary
Fig. 12a). However, Pdcd5 knockdown in AT2 cells had no effects
on fibroblast proliferation or expression of fibrotic target genes
(Supplementary Fig. 12b). Notably, PDCD5 knockdown in
human MRC5 fibroblasts did not affect expression of fibrotic
target genes, again verifying the selective role of PDCD5 in club
cells (Supplementary Fig. 12c). These results were consistent with
our in vivo data showing that Pdcd5 mediates lung fibrosis in a
club cell-specific manner.
Given our data suggesting that TGF-β-induced PDCD5
expression modulates expression of matricellular genes, we next
tested whether PDCD5 selectively regulates club cell-specific
secretion of matricellular proteins in response to TGF-β. After 24
h of TGF-β1 treatment, media from C22, RLE-6TN, and Mlg cells
were harvested and the level of matricellular proteins, including
Periostin, CTGF, TSP-2, and TNC, was assessed by western blot.
TGF-β dramatically increased secretion of matricellular proteins
in C22, AT2, and fibroblast cells. However, Pdcd5 knockdown
selectively reduced TGF-β-induced matricellular protein secretion
in C22 club cells. In contrast, Pdcd5 knockdown in AT2 and Mlg
fibroblast cell lines had no effect on secretion of matricellular
proteins (Fig. 5c). Finally, we assessed changes in matricellular
protein expression in the lung tissue of mice with BLM-induced
fibrosis. Increased levels of BLM-induced CTGF, Periostin, and
TNC were greatly decreased in the lung of Ccsp-Pdcd5d/d mice
when compared with those of control mice (Fig. 5d and
Supplementary Fig. 13). Collectively, these data demonstrate that
club cell-specific PDCD5 mediates fibroblast activation by
promoting secretion of matricellular proteins, which eventually
leads to pulmonary fibrosis.
Discussion
Although the pathogenesis of IPF is not fully understood, it is
believed that abnormal recovery after alveolar epithelium injury
may eventually lead to development of the disease23. Secretion
of various factors from damaged epithelial cells, including TGF-
β, PDGF, and CTGF, promotes differentiation of fibrotic cells
and accumulation of ECM24. Among lung epithelial cells, AT2
cells are the main bronchiolar epithelial cells responsible for
activation of fibroblasts via a paracrine loop, and the majority of
studies have therefore focused on this type cell25. On the other
hand, club cells are non-ciliated bronchiolar exocrine cells that
secrete a variety of proteins into the extracellular space to
protect the bronchiolar epithelium from external damage26. A
recent study showed that depletion of club cells using naph-
thalene reduced pulmonary fibrosis, demonstrating that club
cells are important for development of lung fibrosis27. Club cells
also play a progenitor role to maintain homeostasis of the
Fig. 3 PDCD5 mediates TGF-β-dependent transcriptional activation of matricellular genes via formation of a PDCD5/β-catenin/Smad3 complex. a C22
cells were treated with TGF-β1 (20 ng/ml) and harvested at indicated time points. Whole-cell lysates were analyzed by immunoblotting with indicated
antibodies. Representative blots for three independent experiments are shown. b GSEA of RNA-seq signals of GO-defined ECM gene clusters in C22 cells.
The normalized enrichment score (NES) is pictured in the left panel. A heat map of the ECM gene signature is pictured in the right panel. c Primary club
cells were isolated from Pdcd5f/f and Ccsp-Pdcd5d/d mouse lungs, and AT2 cells were isolated from Pdcd5f/f and Spc-Pdcd5d/d mice after BLM injection. The
levels of indicated genes were analyzed by qRT-PCR. (n= 3 mice/group); *p= 0.0293; **p= 0.0034; ***p < 0.0008; ****p < 0.0001; n.s. not significant. d
C22 cells were transfected with Pdcd5 siRNAs for 36 h and then treated with TGF-β1 for 12 h. Nuclear extracts were immunoprecipitated with the indicated
antibodies and immunoblotted with the indicated antibodies. Representative blots from three independent experiments are shown. e Primary club cells or
AT2 cells from BLM-injected mice were analyzed by in situ PLA, using Smad3 and β-catenin antibodies. Scale bars= 20 µm. Number of signals was
quantified using ImageJ software (n= 5/group); **p= 0.0074; ****p < 0.0001; n.s. not significant. f C22 cells were treated with Pdcd5 siRNA for 36 h and/
or TGF-β1 for 12 h, immunofluorescence analysis was performed. Scale bars= 10 μm. Representative images from three independent experiments are
shown. g C22 cells were treated with TGF-β1 for 24 h and a ChIP assay was performed using the indicated antibodies. Precipitated samples were analyzed
by qRT-PCR, and results are presented as the percentage of input (n= 3 in each group); ****p < 0.0001. Data are shown as mean ± s.e.m. Statistical
analysis was performed with one-way ANOVA with Tukey’s post hoc test (c, e, g). Source data are provided in the Source Data file.
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bronchiolar walls3. Club cells are known to be widely located
from trachea through bronchiole to bronchiolar alveolar duct
junction. In particular, since these cells are located very close to
the alveolar region, they migrate to the alveolar region in case of
severe lung injury and have been reported to be involved in
alveolar bronchiolization by inducing apoptosis in alveolar
epithelial cells. Importantly, TRAIL-expressing club cells were
detected within the affected alveolar epithelia in established
fibrosis of IPF lungs6. However, the role of club cells in the
pathogenesis of pulmonary fibrosis is still unclear. In this study,
we found that PDCD5 mediates transcriptional activation of
matricellular genes in club cells, which leads to activation of
fibroblasts. We provided evidence that PDCD5 selectively
mediates pulmonary fibrosis in a club cell-specific manner, but
not in AT2 cells or fibroblasts. Consequently, we identified the
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suggest that club cells have a significant functional role in pul-
monary fibrosis.
Accumulating studies show that PDCD5 plays important roles
in cell signaling by protein–protein interaction as a molecular
chaperone. Our previous reports show that PDCD5 inhibits
HDAC3–AKT interaction without affecting apoptosis of endo-
thelial cells, which leads to inhibition of nitric oxide production in
the vascular endothelium10. In contrast, in cancer cells, PDCD5
acts as a activator of apoptosis, disrupting HDAC3–p53 interac-
tion to promote p53 activity9. In addition, PDCD5 interacts with
TIP60, which enhances TIP60 stability, thereby promoting
p53 signaling28. These observations suggest that PDCD5 is
involved in regulation of various signaling pathways, including
the cell death pathway. PDCD5 has six α-helices8; deletion of the
first 30 N-terminal residues of PDCD5 abolishes interaction with
p53, and introduction of the L6R PDCD5 mutation leads to
dissociation from HDAC3, suggesting that the N-terminus of
PDCD5 contains an α-helix that plays a key role in
protein–protein interactions9. In this study, we found that
PDCD5 directly interacts with β-catenin, but not Smad3, and
mediates formation of the PDCD5/β-catenin/Smad3 complex.
PDCD5 knockdown abrogated TGF-β-induced formation of the
PDCD5/β-catenin/Smad3 complex and transcriptional activation
of matricellular genes, indicating that PDCD5 acts as a molecular
chaperone that mediates TGF-β signaling. Whether the α-helix-
containing N-terminus of PDCD5 mediates the formation of the
β-catenin/Smad3 complex is still unknown. Further study is
required to understand the structural relationship of PDCD5 with
the β-catenin/Smad3 complex.
Unlike previous findings, we found that p38 MAPK, but not
CK2, directly phosphorylates PDCD5 at Ser-119 to promote its
stability and nuclear translocation in response to TGF-β1 treat-
ment; it is still unclear why CK2 failed to phosphorylate PDCD5
in the context of TGF-β signaling. Since the core enzymes of
each cell act on the basis of respective signal transduction to
regulate the function of target proteins, induction of PDCD5
phosphorylation at Ser-119 upon TGF-β cell signaling is more
likely to be performed by p38 MAPK rather than CK2. It was
recently reported that CK2 phosphorylates JAK2, a pro-fibrotic
mediator in fibroblasts29; thus, CK2 may not be activated in club
cells by TGF-β signaling or may mainly act as a mediator in
fibroblasts. Additional studies will be needed to clarify this
mechanism.
We found that PDCD5 promotes transcriptional activation of
matricellular proteins. These secreted matricellular proteins
interact with structural ECM proteins, such as collagen, which is
required for formation of fibrils. Among those, CTGF is a key
mediator of ECM production, leading to proliferation of lung
fibroblasts and progression of lung fibrosis. CTGF does not
behave like a traditional growth factor or cytokine because it does
not have a specific receptor with a high affinity for signal
transduction30; CTGF may be more accurately described as a
matricellular protein that modulates cell–cell interactions to alter
cellular phenotypes. Overexpression of CTGF promotes fibrosis
in lung, kidney, and skin, and experimental reduction of CTGF
suppresses fibrosis in animal models31. In the context of IPF
therapy, a phase II clinical trial of Pamrevlumab (FG-3019), a
therapeutic antibody against CTGF, has been completed, and
Pamrevlumab is expected to be developed as a next-generation
pulmonary fibrosis treatment due to its significant effects on lung
fibrosis and low toxicity32. In our study, Pdcd5 knockdown in
club cells selectively diminished fibroblast proliferation and col-
lagen synthesis. Furthermore, we observed that TGF-β-induced
secretion of CTGF by club cells, but not AT2 cells, was greatly
reduced following PDCD5 knockdown, indicating PDCD5 is a
key regulator of CTGF secretion in club cells. Consistently, Pdcd5
knockdown also blocked secretion of other matricellular proteins,
including Periostin, CTGF, TSP-2, and TNC, indicating that
PDCD5 is a master regulator of matricellular protein production
in club cells. Recent reports suggest that various types of myofi-
broblasts are involved in induction of pulmonary fibrosis. This
myofibroblast heterogeneity suggests that there is a limit to the
development of lung fibrosis therapy by targeting a single
protein33. Therefore, it is necessary to develop a treatment
method that targets a core molecular circuit or pathway that can
prevent activation of pathologic fibroblasts. Intriguingly, there are
reports that serum PDCD5 levels are implicated in several dis-
eases, such as endothelial dysfunction10, breast, gastrointestinal
tract, lung cancer34, and chronic myeloid leukemia35. In accor-
dance with these findings, we also observed that a significant
amount of PDCD5 protein is present in C22 cell culture as well as
cell lysates (Fig. 5c). Although clinical trials using CTGF anti-
bodies are successfully ongoing, development of a diagnostic or
targeting method of PDCD5 protein present in the blood may
lead to advances in IPF therapy. In addition, α-SMA expression,
which is a marker for EMT and myofibroblasts marker, is also up-
regulated by PDCD5 in club cells. Intriguingly, we also observed
that PDCD5 was highly co-localized with the fibroblast marker α-
SMA in IPF patients, suggesting a plausible role for PDCD5 in
myofibroblast activation during IPF development. Because club
cells are known to act as stem cells, giving rise to ciliated cells
during the regeneration of the bronchiolar epithelium36, further
studies should examine whether PDCD5 mediates the EMT of
club cells or activates myofibroblasts during the development of
pulmonary fibrosis.
Collectively, our results demonstrate that PDCD5 is sig-
nificantly elevated in the lungs of patients with IPF and in mice
with pulmonary fibrosis. PDCD5 mediates TGF-β-induced
matricellular protein secretion via formation of PDCD5/β-cate-
nin/Smad3 complex in club cells, which eventually leads to acti-
vation of fibroblasts and ECM accumulation. Our results suggest
that PDCD5 acts as a pulmonary fibrosis mediator in a club cell-
specific manner. Therefore, our study provides a conceptual
framework for understanding the interconnectivity between club
Fig. 4 p38 MAPK promotes stabilization and nuclear translocation of PDCD5 in a response to TGF-β. a C22 cells were transfected with the indicated
plasmids for 24 h and then treated with TGF-β1 for 12 h. Immunofluorescence staining was performed with a FITC-conjugated Flag antibody. Scale bars=
50 μm. b C22 cells were treated with each of the indicated inhibitors (10 μM SB203580; 10 μM TBB; and 10 μM SP600125) for 2 h before TGF-β1 (20 ng/
ml) treatment. Immunoblotting with the indicated antibodies was then carried out. Representative blots from three independent experiments are shown. c,
e C22 cells were treated with TGF-β1 and/or indicated inhibitors. Immunofluorescence staining was performed with anti-p-PDCD5 and anti-PDCD5
antibodies after 12 h TGF-β1 treatment. Scale bars= 50 μm. d C22 cells were treated with TGF-β1 and/or indicated inhibitors. The levels of indicated genes
were analyzed by qRT-PCR. Error bars, mean ± s.e.m. (n= 3 in each group); ***p < 0.0007; ****p < 0.0001; n.s. not significant, one-way ANOVA with
Tukey’s test f In vitro kinase assay was performed using GST-PDCD5 as a substrate. Error bars, mean ± s.e.m. (n= 3 in each group); ****p < 0.0001.
Statistical analysis was performed with one-way ANOVA with Tukey’s post hoc test (d, f). Radioactive in vitro kinase assay was performed in GST-PDCD5
or PDCD5S119A with p38α recombinant protein. PDCD5 phosphorylation levels were analyzed by autoradiography (lower panel). Representative images
and blots from three independent experiments are shown (a–c, e, f). Source data are provided in the Source Data file.
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Fig. 5 PDCD5 promotes fibroblast activation via secretion of matricellular proteins. a C22 cells were plated on transwells and transfected with
Pdcd5 siRNAs. Mouse primary lung fibroblast cells (MLFs) were plated in 24-well plates a day before TGF-β1 treatment. Transwells were transferred to
Mlg-containing 24-well plates. After 24 h TGF-β1 treatment, MLFs were counted using an automated cell counter (n= 3 in each group); ****p < 0.0001. b
MLFs were cultured in C22 conditioned medium (CM). The levels of indicated genes were analyzed by qRT-PCR (n= 3 in each group) *p= 0.0265; ***p=
0.0002; ****p < 0.0001; n.s. not significant. Error bars represent mean ± s.e.m., statistical analysis was performed with one-way ANOVA followed by
Tukey’s test (a, b). c C22, RLE-6TN, and Mlg cells were treated with TGF-β1 for 24 h. Enriched media and cell lysates were used for immunoblotting with
indicated antibodies. Representative blots from three independent experiments are shown. d IHC with indicated antibodies was performed in the lung
tissue from Pdcd5f/f and Ccsp-Pdcd5d/d mice. Scale bars= 100 μm. Representative images from three mice in each group are shown. Source data are
provided in the Source Data file.
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cells and pulmonary fibrosis, with implications for the diagnosis
and treatment of IPF.
Methods
Patient samples. Human lung tissue samples were obtained from the tissue bank
at Severance Hospital (Seoul, Korea). A total of 19 samples from IPF patients
between September 2015 and December 2016 were included in the study. The
patients fulfilled the criteria of the American Thoracic Society and European
Respiratory Society1, and diagnosis of IPF was supported by history, physical
examination, pulmonary function studies, chest high-resolution computed tomo-
graphy, and corroborated by video-assisted thoracoscopic lung biopsy or transplant
explants. Disease staging was performed using gender–age–physiology (GAP)
index and categorized into stages I to III37. A total of 10 control samples, including
lung samples with normal histology from patients with lung cancer, were also
obtained from the same tissue bank. Informed consent was obtained from all
patients and controls. This study was approved by the ethical committee of the
institutional review board of Severance Hospital and in accordance with regula-
tions (protocol no. 4-2016-0453).
Animal studies. All animal experiments were conducted in accordance with
standard operating guidelines with the approval of Yonsei University College of
Medicine Institutional Animal Care and Use Committee (IACUC No. 2015-0047).
Six- to 8-week-old C57BL/6 male mice were used for this study (Orient Bio. Korea).
We crossbred Pdcd5f/f mice9 with Scgb1a1-CreERTM mice14 (The Jackson
Laboratory, Sacramento, CA, USA) or Sftpc-CreERT217 (gifted from Brigid L.M.
Hogan, Duke University Medical Center) to generate Pdcd5f/f;Scgb1a1Cre/+ mice
(Ccsp-Pdcd5d/d) or Pdcd5f/f;SftpcCre/+ (Spc-Pdcd5d/d) mice. ROSA26-mTmG
mouse18 was crossed to Ccsp-Pdcd5d/d or Spc-Pdcd5d/d mice to visualize Cre-
mediated excision of Pdcd5 in club cells or AT2 cells. To induce knockout of Pdcd5,
10 mg/kg hydroxytamoxifen (4-OHT; Sigma-Aldrich, St. Louis, MO, USA) was
injected into 8-week-old male mice three or four times every other day. Three days
after the last injection, mice were injected with saline (vehicle control) or 4 mg/kg
BLM (Santa Cruz Biotechnology, Santa Cruz, CA, USA) intratracheally. Mice were
sacrificed after receiving bleomycin and BAL fluid and lung tissues were harvested.
Mice were housed in a specific pathogen-free animal facility, with controlled
temperature (~24 °C) and humidity under 12 h light/dark cycle (lights on at 8 a.m.)
and had free access to food and water.
TGF-β1 transgenic mice. Eight-week-old TGF-β1 transgenic mice (Ccsp-rtTA-tTS-
TGF-β1) and littermate controls were randomized to normal water or water con-
taining 0.5 mg/ml of doxycycline (Dox) (Sigma-Aldrich) to induce TGF-β1 over-
expression, as described previously38. To generate club cells with Pdcd5 knockout
and TGF-β1 overexpression, Ccsp-rtTA-tTS-TGF-β1 (Ccsp-TGFβ1-TG) mice were
bred to Pdcd5f/f or Ccsp-Pdcd5d/d mice. After four total injections of 10 mg/kg 4-
OHT to Ccsp-TGFβ1-TG with Ccsp-Pdcd5d/d mice, administered every other day,
and then Dox was administered for 4 weeks (Supplementary Fig. 5b).
Mouse primary cell sorting. Eight-week-old mice were injected with saline or
4 mg/kg BLM, intratracheally. Mice were sacrificed 7 days after BLM injection, and
saline perfused lungs were treated using a mouse lung dissociation kit (Miltenyi
Biotec, Auburn, CA, USA), in the gentleMACSTM Dissociator (Miltenyi Biotec).
Red blood cells (RBCs) were lysed with RBC lysis solution (Miltenyi Biotec), and
isolated cells from the mouse lung were double stained with anti-CCSP/anti-
EpCAM for club cells or anti-CD74/anti-EpCAM for AT2 cells. Isotype control
antibodies (IgG2a κ-FITC and IgG2a κ-APC; eBioscience, San Diego, CA) were
used to establish gating parameters for positively stained cells. Double-positive
populations were sorted using a BD FACSAriaTM III cell sorter (BD Biosciences,
San Jose, CA, USA). Sorted double-positive cells were subjected to an RNeasy
Micro Kit (Qiagen, Germany) to obtain mRNA for qRT-PCR assays or plated on
chamber slides (SPL Life Sciences, Korea) for in situ proximity ligation assay (PLA)
analysis.
Soluble collagen assay. Collagen content in the mouse lung was determined
biochemically using the Sircol Collagen Assay kit (Biocolor, Carrickfergus, UK)
according to the manufacturer’s instructions.
Immunohistochemistry. Mouse lung tissues from each group were fixed in for-
maldehyde (10% w/v) for 48 h at room temperature and embedded in paraffin.
Tissue sections were processed for MTS and IHC. Immunohistochemical staining
was performed as previously described10. The following antibodies were used: anti-
PDCD5 (Proteintech, Rosemont, IL, USA), anti-CTGF, anti-Periostin, and anti-
TNC were purchased from Abcam (Cambridge, MA, USA). Normal rabbit IgG
(Santacruz) was used for non-immune control. To visualize bound antibodies, an
Immunostaining-DAKO Envision Plus kit (DAKO, Santa Cruz, CA, USA)
was used.
Cell culture and reagents. The immortalized mouse club cell line, C22 (Sigma-
Aldrich) was maintained as previously described39. Briefly, cells were maintained in
permissive conditions (Dulbecco’s modified Eagle medium (Corning, Manassas,
VA, USA) supplemented with 2% fetal bovine serum, penicillin [100 U/ml],
streptomycin [100 μg/ml], amphotericin B [250 μg/ml], endothelin-1 [0.25 μg/ml],
interferon-γ [100 U/ml], insulin [10 μg/ml], transferrin [5 μg/ml], endothelial cell
growth supplement [7.5 μg/ml], epidermal growth factor [0.025 μg/ml], hydro-
cortisone [0.36 μg/ml], and T3 [0.02 μg/ml]) at 33 °C prior to experiments, and
then transferred to non-permissive conditions (without interferon-γ) at 37 °C to
inactivate large T-antigen. The rat RLE-6TN AT2 cell line (kindly presented from
Sang Myun Park Ajou University, Korea), mouse Mlg fibroblast cell line, and
human MRC5 fibroblast cell line (Korean cell line bank, Seoul, Korea) were
maintained in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal
bovine serum and 1% antibiotic/antimycotic solution (Corning) at 37 °C in 5%
CO2. Primary mouse fibroblast cells were obtained from Cell Biologics (Chicago,
IL, USA). TGF-β1 was purchased from Prospec (East Brunswick, NJ, USA).
SB203580 (p38 inhibitor) and SP600125 (JNK inhibitor) were purchased from
Selleckchem (Houston, TX, USA). TBB (4,5,6,7-tetrabromobenzotriazole) were
purchased from Sigma-Aldrich.
Fluorescence imaging. Tissue slides were rehydrated in xylene and ethanol and
citrate buffer (DAKO) was used for antigen retrieval. Anti-PDCD5 (R&D Systems,
MN, USA), anti-p-PDCD5 (ref. 9), anti-Flag (Sigma-Aldrich), anti-CCSP (Milli-
pore), anti-pro-SP-C (Santacruz), and anti-PDPN, anti-Scgb3a2 (R&D Systems),
anti-Muc5AC, anti-Foxj1 (Thermo Fisher Scientific), anti-α-SMA, and anti-Ki67
(Abcam) antibodies were incubated at 4 °C overnight and stained with Alexa Fluor
488-, Alexa Fluor 549-, or Alexa Fluor-647-conjugated goat anti-rabbit or anti-
mouse secondary antibodies (Thermo Fisher Scientific). Nuclei were stained with
DAPI (Abcam). Slides were mounted using fluorescence mounting medium
(DAKO). Cryosections from unfixed lungs were embedded in OCT compound.
Frozen sections (5-μm-thick) were cut with a cryostat at −20 °C and mounted with
DAPI-containing mounting medium (Sigma-Aldrich). TUNEL-positive cells were
detected using In Situ Cell Death Detection Kit (Sigma-Aldrich).
Cells were cultured on chamber slides (SPL Life Sciences, Korea) and fixed in
4% paraformaldehyde for 30 min at room temperature. After washing with
phosphate-buffered saline (PBS), fixed cells were permeabilized with 0.1% Triton
X-100) and incubated for 20 min with 3% bovine serum albumin to block
nonspecific antibodies. Cells were incubated with primary antibodies for overnight,
and then incubated with secondary antibodies. The slides were mounted with
DAPI-containing mounting medium (Abcam), then imaged using an LSM 710
Laser Scanning Microscope (Carl Zeiss, Germany) and co-localization and mean
intensity profiles were analyzed using ZEN 3.0 (black edition) software.
Western blot analysis and immunoprecipitation. Cells were lysed in lysis buffer
(20 mM Tris-Cl, 150 mM NaCl, 1% Triton X-100, 1.5% MgCl2, 1 mM ethylene-
diaminetetraacetate, 1 mM Na2VO4, 1 mM phenylmethylsulfonyl fluoride, and
protease inhibitor cocktail at pH 7.5). Lysates were briefly vortexed and cleared by
centrifugation at 16,000 × g for 20 min at 4 °C; supernatants were collected and
transferred to fresh tubes. Protein concentrations were determined using a 660-nm
protein assay reagent (Thermo Fisher Scientific, Rockford, CT, USA). The samples
were then precleared with protein A/G agarose beads (Santa Cruz) for 2 h and
precipitated using protein A/G agarose beads. Equal amounts of protein extracts
and immunoprecipitation products were subjected to electrophoresis on sodium
dodecyl sulfate-polyacrylamide gels and transferred to nitrocellulose transfer
membranes (Whatman, Dassel, Germany). The membranes were blocked in Tris-
buffer (pH 7.4) containing 0.1% (v/v) Tween 20 (Sigma-Aldrich) and 5% (w/v)
nonfat Difco skim milk (BD Biosciences, San Jose, CA, USA), and then probed with
primary antibodies. The following antibodies were used: anti-p-PDCD5 Ser-119
(ref. 9), anti-PDCD5 (Proteintech; R&D Systems, MN, USA; Abcam); Anti-Smad2,
anti-Smad3, anti-p-Smad2, anti-p-Smad3, anti-p38, anti-pp38, and Lamin A/C
antibodies (Cell Signaling, Danvers, MA, USA); anti-Periostin, anti-CTGF, anti-
TSP-2, and anti-TNC (Abcam); anti-HA and anti-GAPDH (Santa Cruz), anti-β-
catenin (BD Biosciences), anti-FLAG and anti-β-actin (Sigma-Aldrich). The
membranes were then washed with 1× PBST, incubated with the appropriate
secondary anti-rabbit or anti-mouse horseradish peroxidase-conjugated antibodies
(Thermo Scientific, Rockford, IL, USA) for 1 h, and visualized using the LAS-3000
system (Fujifilm, Stamford, CT, USA) with an enhanced chemiluminescence
detection reagent (Thermo Scientific).
RNA isolation and quantitative RT-PCR. Total RNA from cells was prepared
using Ribospin II (GeneAll Biotech, Korea), and cDNA was synthesized using
Cellscript (CellSafe, Korea). For RNA sequencing, quality was assessed using an
Agilent 2100 bioanalyzer and RNA 6000 Nano Chip (Agilent Technologies,
Amstelveen, The Netherlands). PCR primer sequences for qRT-PCR are listed in
Supplementary Table 2. We normalized the concentration of cDNA using mouse
Tuba-1b, rat 18s, or human ACTB. qRT-PCR analyses were performed using SYBR
Green PCR master mix reagents and an ABI Prism 7700 sequence detection system
(Applied Biosystems, Carlsbad, CA, USA). All reactions were carried out in
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triplicate. Relative expression levels and standard deviation were calculated using
the comparative method.
Library preparation and sequencing. For control and test RNAs, library con-
struction was performed using a QuantSeq 3′ mRNA-seq Library Prep kit (Lexo-
gen, Inc., Austria) according to the manufacturer’s instructions. In brief, 500 ng of
each RNA was prepared and an oligo-dT primer containing an Illumina-
compatible sequence at its 5′ end was hybridized to the RNA and reverse tran-
scription was performed. After degradation of the RNA template, second strand
synthesis was initiated using a random primer containing an Illumina-compatible
linker sequence at its 5′ end. The double-stranded library was purified using
magnetic beads to remove all reaction components. The library was amplified to
add the complete adapter sequences required for cluster generation. The finished
library therefore consisted of purified PCR components. High-throughput
sequencing was performed as single-end 75 sequencing using NextSeq 500 (Illu-
mina, Inc., USA).
Data analysis. QuantSeq 3′ mRNA-seq reads were aligned using Bowtie2 (version
2.3.4.3)40. Bowtie2 indices were either generated from the genome assembly
sequence or the representative transcript sequences for aligning to the genome and
transcriptome. The alignment file was used for assembling transcripts, estimating
abundances, and detecting differential gene expression. Differentially expressed
genes were determined based on counts from unique and multiple alignments
using coverage in Bedtools (version 2.26)41. The RC (read count) data were pro-
cessed using the quantile normalization method with EdgeR within R version 4.0.3
(R development Core Team, 2016) using Bioconductor42. GSEA was performed
using GSEA version 4.0.1 software (Broad Institute). Gene sets were obtained from
the Molecular Signatures Database (MSigDB, version 7.0). Gene classification was
based on searches done by DAVID (vesion 6.8; http://david.abcc.ncifcrg.gov/).
ChIP assay. ChIP was carried out on 107 C22 cells using a Pierce Agarose ChIP kit
(Thermo Fisher Scientific) according to the manufacturer’s instructions. The
nuclear lysates were precipitated with anti-PDCD5 (R&D Systems), anti-p-Smad3
(Cell Signaling), anti-β-catenin (BD Biosciences), or normal rabbit IgG (Thermo
Fisher Scientific) antibodies overnight at 4 °C together with ChIP-grade protein
A/G agarose beads. The beads were then washed, eluted, and treated with pro-
teinase K. The recovered DNA was amplified by qRT-PCR using primers listed in
Supplementary Table 2.
In situ PLA analysis. In situ PLA analysis (Sigma-Aldrich) was carried out fol-
lowing the manufacturer’s instructions. Cells were fixed with 4% paraformalde-
hyde, washed with PBS, and blocked with blocking solution. After the application
of p-Smad3 and β-catenin antibodies, cells were incubated with PLUS and MINUS
secondary PLA probes based on species and then subjected to ligation and
amplification using the provided reagents. The samples were mounted with
Duolink mounting medium and analyzed using an LSM 710 Laser Scanning
Microscope (Carl Zeiss).
p38 in vitro kinase assay. The p38 in vitro kinase assay was performed using the
p38α kinase assay kit (Promega, Madison, WI, USA) according to the manu-
facturer’s instructions. Purified GST, GST-PDCD5, and GST-PDCD5 S119A were
used as substrates. For radioactive in vitro kinase assay, GST-fusion proteins were
incubated with 1 μg of recombinant p38α (Promega) in the presence of kinase
reaction buffer (12.5 mM MgCl2/100 mM ATP plus 100 μCi of [γ-32P]-ATP) in a
total volume of 50 μl for 2 h at 30 °C. Reaction were terminated by washing twice
with 1× kinase buffer. Samples were resuspended in 15 μl 5× SDS sample loading
buffer and boiled for 5 min. After electrophoresis, SDS polyacrylamide gel was
stained with Coomassie blue and dried, and the phosphorylated products were
visualized by autoradiography.
Media concentration and co-culture. Medium from C22, RLE-6TN, or Mlg cells
cultured in 60-mm cell culture dishes was harvested, passed through a 0.45 μm
filter (Sartorious, Stonehouse, UK), and used as conditioned medium. Additionally,
culture medium was applied to a VIVASPIN6 column (Sartorious) and centrifuged
for 3 h at 10,000 × g; concentrated protein was calculated using a protein assay, and
then immunoblotted using antibodies. For co-culture, C22 or RLE-6TN cells were
plated on Transwell inserts (Corning) with 0.45 μm pores, which allowed free flux
of secreted proteins between the two cell types.
Statistical analysis. Statistical analyses of human data were conducted with R
(version 3.3.2; R Foundation for Statistical Computing, Vienna, Austria). Con-
tinuous data were reported as the mean (± standard deviation [SD]) or median
(interquartile range). Comparisons of two groups were performed using a Student’s
t-test or Mann–Whitney U-test for continuous variables, and the chi-square test or
Fisher’s exact test was used to analyze categorical variables. Experimental results
were visualized and analyzed with Prism version 9 (GraphPad Software) and are
depicted as the mean ± standard error of the mean (s.e.m.). For a two-group
comparison, a Mann–Whitney U-test or Student’s t-tests were used. P values < 0.05
were considered statistically significant. When more than two groups of samples
were compared, a one-way ANOVA was used. Tukey’s range test was used for post
hoc analyses of ANOVA.
Reporting summary. Further information on experimental design is available in
the Nature Research Reporting Summary linked to this paper.
Data availability
RNA-Sequencing data have been deposited in the NCBI Gene Expression Omnibus and
are accessible through GEO Series, using accession number GSE143841. All other data
supporting the findings from this study are available on reasonable request. Source data
are provided with this paper.
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